Tumor News and Research

RSS

Researchers identify cell cue for destroying tumors

Mayo Clinic researchers have identified and characterized an important signal used by the human immune system to help destroy tumors.

4 Apr 2006

Immune response protects against brain tumor development

In their quest to determine whether immune system surveillance guards against brain tumor development, researchers at The University of Texas M. D. Anderson Cancer Center have found that allergies and asthma that stimulate inflammation may be protective, but use of antihistamines to control the inflammation could eliminate that protection.

4 Apr 2006

Omega-3 fatty acids inhibit the growth of liver cancer cells

Two new studies by a University of Pittsburgh research team suggest that omega-3 fatty acids - substances that are found in high concentrations in fish oils and certain seeds and nuts - significantly inhibit the growth of liver cancer cells.

3 Apr 2006

Laughter is the best medicine

There's no doubt that laughter feels good, but is there real neurophysiology behind it and what can you do about it?

3 Apr 2006

Doctors able to predict recurrence of high-risk breast cancers

International researchers have developed a prediction model to assist doctors in determining the chance of recurrence of cancer in high-risk breast cancer patients who have undergone a mastectomy followed by radiation therapy.

3 Apr 2006

Serum tumor markers predict extravesical disease in clinical stage T2 bladder cancer

Bladder cancer clinical staging is notoriously poor in patients with muscle invasive disease.

31 Mar 2006

Weill Cornell researchers identify tumor-suppressor gene important to diffuse large B-cell lymphomas

Inactivation of a "tumor suppressor" gene could be a major cause of a class of blood cancers called diffuse large B-cell lymphomas, reports a team of researchers at the Weill Medical College of Cornell University.

30 Mar 2006

Mouse Brain Gene Expression Map at St. Jude - powerful new tool for studying brain development

Scientists at St. Jude Children's Research Hospital have given investigators around the world free access to a powerful tool for studying brain development.

28 Mar 2006

Inducing melanoma for cancer vaccine development

Cancer vaccines are being investigated in early-phase clinical trials around the world, with many of those trials recruiting patients with melanoma.

28 Mar 2006

New way of targeting proteins to exosomes - potential for melanoma, Alzheimer's disease

Researchers at the University of Pennsylvania School of Medicine have discovered how a protein called Pmel17 is sorted by pigment cells in the skin and eye to make a fiber matrix that eventually sequesters melanin, the dark pigment found in skin, hair, and eyes.

28 Mar 2006

First trial to combine a biologic agent with a conventional chemotherapy agent for the treatment of ovarian cancer

Researchers found the addition of thalidomide to topotecan for the treatment of recurrent ovarian cancer significantly increases the response to therapy and the duration of progression free survival without additional toxicity.

28 Mar 2006

Gene therapy treatment for brain tumours and infections

In a study published in the March 15 issue of The Journal of Immunology, researchers at Board of Governors' Gene Therapeutics Research Institute at Cedars-Sinai Medical Center have developed a way to overcome immune privilege in the brain to eradicate potentially deadly brain tumors such as glioblastoma multiforme and other types of brain infections.

27 Mar 2006

Light activated anticancer drug targeted to DNA using cisplatin like sub-units: Coupling light absorbers to reactive metal centers

One of the most effective chemotherapy drugs against cancer is cisplatin because it attaches to cancer DNA and disrupts repair. However, it also kills healthy tissue. Many scientists are creating alternative drugs or cisplatin analogs in attempts to find treatments without side effects.

27 Mar 2006

Evolutionary biology research predicts precancerous tumors

In diverse ecosystems, packed with wildly different species, evolution whizzes along. As different species accumulate mutations, some adapt particularly well to their environment and prosper.

27 Mar 2006

Why do men choose one prostate treatment over another?

Men with prostate cancer generally make treatment decisions based on differences in the information they receive rather than their own preferences, according to a new review.

27 Mar 2006

Delayed prostate cancer intervention in low risk patients may not decrease ultimate chance for cure

A contemporary discussion exists whether patients with low-risk prostate cancer (CaP) are being overtreated with local treatment modalities. This is due to a combination of the older population affected and the slow doubling time of CaP.

23 Mar 2006

Positron emission tomography identifies esophageal cancer patients who will respond well to treatment

New research at Wake Forest University Baptist Medical Center shows that Positron Emission Tomography (PET) is more accurate than conventional imaging in identifying patients who have good responses to chemotherapy and radiation treatment - a finding that could one day help some patients avoid surgery.

22 Mar 2006

Computerized tomography guided percutaneous renal cryoablation with the patient under conscious sedation

When an event occurs once, we have a tendency to look at it as a phenomenon, but when it occurs twice, it begins to enter the realm of accepted reality.

21 Mar 2006

New technology - desorption electrospray ionization detects the boundaries of cancerous tumors

Researchers at Purdue University have shown how a new ultra-fast chemical-analysis tool has numerous promising uses for detecting everything from cancer in the liver to explosives residues on luggage and "biomarkers" in urine that provide an early warning for diseases.

21 Mar 2006

Donepezil (Aricept) helps cognitive function in brain tumor patients after radiation

A drug that is marketed to treat Alzheimer's disease also improves cognitive function, mood and quality of life in brain tumor patients following radiation therapy, according to a research team at Wake Forest University Baptist Medical Center.

21 Mar 2006

Tumor News and Research

Researchers identify cell cue for destroying tumors

Immune response protects against brain tumor development

Omega-3 fatty acids inhibit the growth of liver cancer cells

Laughter is the best medicine

Doctors able to predict recurrence of high-risk breast cancers

Serum tumor markers predict extravesical disease in clinical stage T2 bladder cancer

Weill Cornell researchers identify tumor-suppressor gene important to diffuse large B-cell lymphomas

Mouse Brain Gene Expression Map at St. Jude - powerful new tool for studying brain development

Inducing melanoma for cancer vaccine development

New way of targeting proteins to exosomes - potential for melanoma, Alzheimer's disease

First trial to combine a biologic agent with a conventional chemotherapy agent for the treatment of ovarian cancer

Gene therapy treatment for brain tumours and infections

Light activated anticancer drug targeted to DNA using cisplatin like sub-units: Coupling light absorbers to reactive metal centers

Evolutionary biology research predicts precancerous tumors

Why do men choose one prostate treatment over another?

Delayed prostate cancer intervention in low risk patients may not decrease ultimate chance for cure

Positron emission tomography identifies esophageal cancer patients who will respond well to treatment

Computerized tomography guided percutaneous renal cryoablation with the patient under conscious sedation

New technology - desorption electrospray ionization detects the boundaries of cancerous tumors

Donepezil (Aricept) helps cognitive function in brain tumor patients after radiation

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News